Sphere Fluidics strengthens global commercial teams and establishes direct sales and support channel in North America News Sphere Fluidics strengthens global commercial teams and establishes direct sales and support channel in North America
We Invest In People – Gold Accreditation, with Denise Emsden, our Vice-President of People and Organizational Development Blog We Invest In People – Gold Accreditation, with Denise Emsden, our Vice-President of People and Organizational Development
Sphere Fluidics announces Cyto-Mine® Chroma to accelerate and streamline workflows News Sphere Fluidics announces Cyto-Mine® Chroma to accelerate and streamline workflows
Spotlight Series Q&A: Interview with Denise Emsden, VP of People and Organizational Development Blog Spotlight Series Q&A: Interview with Denise Emsden, VP of People and Organizational Development
Sphere Fluidics appoints Dr. Alex Dickinson as Non-Executive Director News Sphere Fluidics appoints Dr. Alex Dickinson as Non-Executive Director
Spotlight Series Q&A: Interview with Rob Treanor, VP of Operations Blog Spotlight Series Q&A: Interview with Rob Treanor, VP of Operations
Sphere Fluidics awarded gold accreditation by Investors in People News Sphere Fluidics awarded gold accreditation by Investors in People
Sphere Fluidics launches Cyto-Cellect®PLUS to accelerate cell line development workflows News Sphere Fluidics launches Cyto-Cellect®PLUS to accelerate cell line development workflows
Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets News Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets
Revolutionizing Biologics Discovery: The Impact of Cyto-Mine® at KU Leuven Blog Revolutionizing Biologics Discovery: The Impact of Cyto-Mine® at KU Leuven